We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Office-Based Asthma Screening Intervention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00156468
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : May 12, 2011
Halcyon Hill Foundation
Robert Wood Johnson Foundation
Information provided by:
University of Rochester

September 8, 2005
September 12, 2005
May 12, 2011
October 2003
Not Provided
"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Same as current
Complete list of historical versions of study NCT00156468 on ClinicalTrials.gov Archive Site
Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.
Same as current
Not Provided
Not Provided
Office-Based Asthma Screening Intervention
Office-Based Asthma Screening Intervention
In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Prevention
Behavioral: Provider Prompt
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
September 2005
Not Provided

Inclusion Criteria:

  • Children ages 2-12
  • Children arriving for an office visit in two Rochester, NY pediatric clinics
  • Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

  • Children arriving at the office visit with an adult that is not their parent or guardian
  • Children arriving at the office visit with a parent or guardian that does not speak English
  • Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
Sexes Eligible for Study: All
2 Years to 12 Years   (Child)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Not Provided
Not Provided
University of Rochester
  • Halcyon Hill Foundation
  • Robert Wood Johnson Foundation
Principal Investigator: Jill S Halterman, MD, MPH University of Rochester
University of Rochester
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP